UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Impact of customer satisfaction on business performance of SME’s in Nigeria

International Journal of Research in Business and Social Science, 2021-01, Vol.10 (5), p.46-51

2021

Volltextzugriff (PDF)

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

The lancet oncology, 2023-12, Vol.24 (12), p.1399-1410

2023

Volltextzugriff (PDF)

Tumor downsizing following neoadjuvant therapy for borderline-resectable pancreatic adenocarcinoma

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.690-690

2020

Volltextzugriff (PDF)

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

The lancet. Gastroenterology & hepatology, 2020-03, Vol.5 (3), p.285-294

2020

Volltextzugriff (PDF)

Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Journal of clinical oncology, 2023-04, Vol.41 (11), p.2007-2019

2023

Volltextzugriff (PDF)

Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo : Clinical implications for cancer treatment

Cytotherapy (Oxford, England), 2016-05, Vol.18 (5), p.653-663

2016

Volltextzugriff (PDF)

A phase II study of nab-paclitaxel plus ramucirumab for the second-line treatment of patients with metastatic gastroesophageal cancer

Journal of clinical oncology, 2020-02, Vol.38 (4_suppl), p.365-365

2020

Volltextzugriff (PDF)

A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild‐Type Colorectal Cancer With Liver Metastases Only

The oncologist (Dayton, Ohio), 2016-03, Vol.21 (3), p.279-280d

2016

Volltextzugriff (PDF)

A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers

Cancer investigation, 2016-05, Vol.34 (5), p.213-219

2016

Volltextzugriff (PDF)

Low Dose Thymoglobulin Results In Improved Outcomes After Allogeneic Unrelated Hematopoietic Stem Cell Transplantation (HCT) For Patients With Acute Myeloid Leukemia/ Myelodysplastic Syndrome Conditioned With Intravenous Busulfan and Fludarabine

Blood, 2013-11, Vol.122 (21), p.5453-5453

2013

Volltextzugriff (PDF)

Phase II study of FOLFOXIRI plus panitumumab (pmab) followed by evaluation for resection, in patients (pts) with metastatic KRAS wild-type colorectal cancer (mCRC) with liver metastases only

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e14552-e14552

2014

Volltextzugriff (PDF)

In Vivo Expansion of NK Cells Stimulated with PM21 Particles Under Ultralow IL-2

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.S51-S51

2015

Volltextzugriff (PDF)

The Impact of Continuity of Care On Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation; Improved Overall Survival in the Absence of Severe Graft Vs. Host Disease

Blood, 2012-11, Vol.120 (21), p.4521-4521

2012

Volltextzugriff (PDF)

Bevacizumab, pertuzumab, and sandostatin for patients (pts) with advanced neuroendocrine cancers (NET)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4127-4127

2012

Volltextzugriff (PDF)

Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach

Biology of blood and marrow transplantation, 2015-04, Vol.21 (4), p.632-639

2015

Volltextzugriff (PDF)

324 - Residual Leukemia in the Bone Marrow and/or Peripheral Blood on Day 7 of Blinatumomab Therapy Predicts Response in B-Cell Acute Lymphoblastic Leukemia

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S237-S237

2018

Volltextzugriff (PDF)

Residual Leukemia in the Bone Marrow and/or Peripheral Blood on Day 7 of Blinatumomab Therapy Predicts Response in B-Cell Acute Lymphoblastic Leukemia

Biology of blood and marrow transplantation, 2018-03, Vol.24 (3), p.S237

2018

Volltextzugriff (PDF)

Effect of multiple micronutrient-fortified bouillon on micronutrient status among women and children in the Northern Region of Ghana: Protocol for the Condiment Micronutrient Innovation Trial (CoMIT), a community-based randomized controlled trial

PloS one, 2024-05, Vol.19 (5), p.e0302968-e0302968

2024

Volltextzugriff (PDF)

Multiple fault localization of software programs: A systematic literature review

Information and software technology, 2020-08, Vol.124, p.106312, Article 106312

2020

Volltextzugriff (PDF)

Urban sprawl analysis and shoreline extraction in Douala-Cameroon city using optical and radar sensors

Geocarto international, 2022-12, Vol.37 (26), p.14596-14608

2022

Volltextzugriff (PDF)

EVALUATION OF VITAMIN K2 IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Georgian medical news, 2023-10 (343), p.14-17

2023

Volltextzugriff (PDF)

A Review of Conceptual Design and Self Health Monitoring Program in a Vertical City: A Case of Burj Khalifa, U.A.E

Buildings (Basel), 2023-04, Vol.13 (4), p.1049

2023

Volltextzugriff (PDF)

New Insight into the Possible Roles of L-Carnitine in a Rat Model of Multiple Sclerosis

Brain sciences, 2024-01, Vol.14 (1), p.23

2024

Volltextzugriff (PDF)

Synthesis of diindolylmethane (DIM) bearing thiadiazole derivatives as a potent urease inhibitor

Scientific reports, 2020-05, Vol.10 (1), p.7969-7969, Article 7969

2020

Volltextzugriff (PDF)

Quest for an Innovative Methodology for Retrofitting Urban Built Heritage: An Assessment of Some Historic Buildings in Kano Metropolis, Nigeria

Buildings (Basel), 2023-08, Vol.13 (8), p.1899

2023

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(16)
Humans
(12)
Female
(8)
Male
(8)
Technology
(7)
Computer Science
(5)
Middle Aged
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Nigeria
(4)
Physical Sciences
(4)
Public, Environmental & Occupational Health
(4)
Adolescent
(3)
Adult
(3)
Analysis
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Engineering
(3)
Epidemics
(3)
Geology
(3)
Geosciences, Multidisciplinary
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of customer satisfaction on business performance of SME’s in Nigeria

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Tumor downsizing following neoadjuvant therapy for borderline-resectable pancreatic adenocarcinoma

Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study

Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial

Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo : Clinical implications for cancer treatment

A phase II study of nab-paclitaxel plus ramucirumab for the second-line treatment of patients with metastatic gastroesophageal cancer

A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild‐Type Colorectal Cancer With Liver Metastases Only

A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers

Low Dose Thymoglobulin Results In Improved Outcomes After Allogeneic Unrelated Hematopoietic Stem Cell Transplantation (HCT) For Patients With Acute Myeloid Leukemia/ Myelodysplastic Syndrome Conditioned With Intravenous Busulfan and Fludarabine

Phase II study of FOLFOXIRI plus panitumumab (pmab) followed by evaluation for resection, in patients (pts) with metastatic KRAS wild-type colorectal cancer (mCRC) with liver metastases only

In Vivo Expansion of NK Cells Stimulated with PM21 Particles Under Ultralow IL-2

The Impact of Continuity of Care On Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation; Improved Overall Survival in the Absence of Severe Graft Vs. Host Disease

Bevacizumab, pertuzumab, and sandostatin for patients (pts) with advanced neuroendocrine cancers (NET)

Generation of Highly Cytotoxic Natural Killer Cells for Treatment of Acute Myelogenous Leukemia Using a Feeder-Free, Particle-Based Approach

324 - Residual Leukemia in the Bone Marrow and/or Peripheral Blood on Day 7 of Blinatumomab Therapy Predicts Response in B-Cell Acute Lymphoblastic Leukemia

Residual Leukemia in the Bone Marrow and/or Peripheral Blood on Day 7 of Blinatumomab Therapy Predicts Response in B-Cell Acute Lymphoblastic Leukemia

Effect of multiple micronutrient-fortified bouillon on micronutrient status among women and children in the Northern Region of Ghana: Protocol for the Condiment Micronutrient Innovation Trial (CoMIT), a community-based randomized controlled trial

Multiple fault localization of software programs: A systematic literature review

Urban sprawl analysis and shoreline extraction in Douala-Cameroon city using optical and radar sensors

EVALUATION OF VITAMIN K2 IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

A Review of Conceptual Design and Self Health Monitoring Program in a Vertical City: A Case of Burj Khalifa, U.A.E

New Insight into the Possible Roles of L-Carnitine in a Rat Model of Multiple Sclerosis

Synthesis of diindolylmethane (DIM) bearing thiadiazole derivatives as a potent urease inhibitor

Quest for an Innovative Methodology for Retrofitting Urban Built Heritage: An Assessment of Some Historic Buildings in Kano Metropolis, Nigeria

Suchergebnisse filtern